🔎 Trials Near Me

Početna › Bolesti pluća › Massachusetts › Boston

Kliničke studije za Bolesti pluća u gradu Boston, MA

14 studija za Bolesti pluća traži sudionike na lokacijama u gradu Boston i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

U tijeku regrutacijaFaza 3
  • Dana-Farber Cancer Institute, Boston
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT06765109

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

U tijeku regrutacijaFaza 3
  • Brigham and Women's Hospital, Boston
Od 12 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06679140

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

U tijeku regrutacijaFaza 3
  • Brigham and Women's Hospital, Boston
  • Clinical Trials Center, Boston
  • Clinical Trials Hub, Boston
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT07013474

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

U tijeku regrutacijaFaza 2
  • Brigham and Women's Hospital, Boston
Od 40 do 75 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07759245

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

U tijeku regrutacijaFaza 1/2
  • Dana Farber Cancer Institute, Boston
Od 18 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT06128551

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

U tijeku regrutacijaFaza 3
  • Boston Medical Center, Boston
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT06119581

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

U tijeku regrutacijaFaza 2
  • Clinical Research Site, Boston
Od 18 do 85 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT07333183

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

U tijeku regrutacijaFaza 2
  • Beth Israel Deaconess Medical Center, Boston
Od 18 godina i više · Oba spola · Ažurirano 1. ruj 2026. · NCT05967689

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

U tijeku regrutacijaFaza 2
  • Dana-Farber Cancer Institute, Boston
  • Boston Children's Hospital, Boston
  • Brigham and Women's Hospital, Boston
Od 18 godina i više · Oba spola · Ažurirano 10. lip 2026. · NCT05922761

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

U tijeku regrutacijaFaza 1/2
  • Massachusetts General Hospital,, Boston
Od 12 godina i više · Oba spola · Ažurirano 27. svi 2026. · NCT03093116

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

U tijeku regrutacija
  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Od 18 godina i više · Oba spola · Ažurirano 19. velj 2026. · NCT02984761

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

U tijeku regrutacijaFaza 2
  • Dana-Farber Cancer Institute, Boston
Od 18 godina i više · Oba spola · Ažurirano 15. pro 2025. · NCT06619561

Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System

U tijeku regrutacija
  • Brigham and Women's Hospital, Boston
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2025. · NCT04555161

Studije za Bolesti pluća u drugim gradovima

Ostale studije u gradu Boston

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.